Global Kidney Cancer Diagnostics Market Analysis and Forecast: Revenue of US$ 700 Mn by 2022-End

A fresh study, covering “Kidney Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare Market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make the research a powerful source for analysts and industry experts who are looking to gain necessary knowledge about the prevailing market trends, opportunities and drivers present in the Kidney Cancer Diagnostics Market.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=56

Hospital-associated Labs will Remain Preferred for Kidney Cancer Diagnostics

On the basis of end-users, hospital-associated labs are estimated to remain preferred for kidney cancer diagnostics, accounting for the largest revenues by 2022-end. Independent diagnostic laboratories will continue to be the second most lucrative end-users in the global kidney cancer diagnostics market. In addition, cancer research institutes are expected to register the highest CAGR in the market through 2022.

Immunochemistry tests will continue to be sought-after for kidney cancer diagnostics, with revenues expected to reach US$ 351.8 Mn by 2022-end. This test type segment is projected to register the highest CAGR in the market through 2022, followed by complete blood count test.

Urine analysis will remain the second largest adopted tests for kidney cancer diagnostics across the globe. However, revenues from blood chemistry tests of kidney cancer diagnostics will continue to be lower as compared to rest of the test segments in the market.

North America to Remain the Largest Market for Kidney Cancer Diagnostics

In terms of revenues, North America is expected to remain the largest market for kidney cancer diagnostics, followed by Europe. However, kidney cancer diagnostics market in Europe will exhibit a comparatively higher CAGR than North America during the forecast period. In addition, Asia Pacific excluding Japan (APEJ) will continue to be the fastest expanding market for kidney cancer diagnostics through 2022.

Competition Tracking

Myriad Genetics Inc, NeoGenomics Laboratories, NanoString Technologies Inc., Sysmex Corporation, Rosetta Genomics, Illumina, Inc., Quest Diagnostics Incorporated, Roche Holding AG, Thermo Fisher Scientific Inc., and Abbott Laboratories are observed as key players in the global market for kidney cancer diagnostics.

Browse Full Report With TOC- https://www.factmr.com/report/56/kidney-cancer-diagnostics-market

Table of Content

Chapter 1 Global Kidney Cancer Diagnostics Market - Executive Summary 13

Chapter 2 Global Kidney Cancer Diagnostics Market Overview 15
2.1 Introduction 15
      2.1.1 Global Kidney Cancer Diagnostics Market Taxonomy 15
      2.1.2 Global Kidney Cancer Diagnostics Market Definition 15
2.2 Global Kidney Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022 16
      2.2.1 Global Kidney Cancer Diagnostics Market Y-o-Y Growth 16
2.3 Global Kidney Cancer Diagnostics Market Dynamics 16
      2.3.1 Drivers 16
      2.3.2 Restraints 17
      2.3.3 Trends 17
2.4 Supply Chain 17
2.5 Epidemiology 17
2.6 List of Distributors 17
2.7 Average Pricing Analysis 18
2.8 Regulations 18
2.9 Key Participants Market Presence (Intensity Map) By Region 18

Chapter 3 Global Kidney Cancer Diagnostics Market Analysis and Forecast By Test Type 19
3.1 Global Kidney Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022 19
      3.1.1 Immunohistochemistry Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 19
              3.1.1.1 Revenue (US$ Mn) Comparison, By Region 19
              3.1.1.2 Market Share Comparison, By Region 21
              3.1.1.3 Y-o-Y growth Comparison, By Region 21
      3.1.2 Urine Analysis Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 22
              3.1.2.1 Revenue (US$ Mn) Comparison, By Region 22
              3.1.2.2 Market Share Comparison, By Region 24
              3.1.2.3 Y-o-Y growth Comparison, By Region 24
      3.1.3 Complete Blood Count Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 25
              3.1.3.1 Revenue (US$ Mn) Comparison, By Region 25
              3.1.3.2 Market Share Comparison, By Region 27
              3.1.3.3 Y-o-Y growth Comparison, By Region 27
3.1.4 Blood Chemistry Test Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 28
              3.1.4.1 Revenue (US$ Mn) Comparison, By Region 28
              3.1.4.2 Market Share Comparison, By Region 30
              3.1.4.3 Y-o-Y growth Comparison, By Region 30

Continue…..

Request For Discount On This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=56

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/

This release was published on openPR.